FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 303:776-781 October 2, 1980 Number 14 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We administered phenytoin (diphenylhydantoin) by mouth to 17 unselected patients to assess its ability to reduce blistering in recessive dystrophic epidermolysis bullosa (RDEB). Therapeutic response was correlated with blood levels of the drug. Although there was a decrease in blistering of 53 +/- 6 per cent (mean +/- S.E.) among all patients at levels of more than 8 microgram of phenytoin per milliliter, the response was variable, with 12 of 17 patients having a decrease in blistering of more than 40 per cent. Since increased collagenase in human skin has been implicated in the pathogenesis of blistering in RDEB, we examined the effect of phenytoin on this enzyme. Although the drug did not inhibit collagenase activity directly, its addition to human-skin explant and fibroblast cultures produced a 50 to 60 per cent decrease in collagenase activity and immunoreactive protein concentrations. These in vitro studies suggest that phenytoin inhibits synthesis or secretion of collagenase of both, and that the favorable clinical response can be explained by this inhibition.

This article has been cited by other articles:

• Fine, J.-D., Eady, R. A. J. (1999). Tetracycline and Epidermolysis Bullosa Simplex: A New Indication for One of the Oldest and Most Widely Used Drugs in Dermatology?. Arch Dermatol 135: 981-982 [Full Text]  
• O'Toole, M. J., Kolb, J. E., Lindblad, W. J., Cohen, I. K., McKneally, M. F. (1996). Pneumothorax and Wound Dehiscence Related to Collagenase Deregulation: Treatment With Diphenylhydantoin. Ann. Thorac. Surg. 61: 1646-1650 [Abstract] [Full Text]  
• McAllister, B. S., Walters, J. D., Olson, M. S. (1994). Signal Transduction Mechanisms in Mesenchymal Cells. fake Crit Rev Oral Biol Med 5: 291-310 [Abstract] [Full Text]  
• Golub, L. M., Ramamurthy, N.S., McNamara, T. F., Greenwald, R. A., Rifkin, B. R. (1991). Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs. fake Crit Rev Oral Biol Med 2: 297-321 [Abstract] [Full Text]